Vividion Names Patty Allen as Full-Time Chief Financial Officer and Welcomes Brian Koh, M.D., as Head of Translational Sciences and Clinical Development
SAN DIEGO–(BUSINESS WIRE)–Vividion Therapeutics, Inc., a biotechnology company utilizing novel discovery technologies to unlock high…
Waldencast announces conclusion of SEC investigation